110
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Practices and Hindrances in Cancer Pain Management: Results of a National Multi-Cancer Center Survey Among Healthcare Professionals in China

, , , , , , , ORCID Icon, ORCID Icon & show all
Pages 1709-1717 | Published online: 18 Feb 2021

References

  • van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain. 2007;132(3):312–320. doi:10.1016/j.pain.2007.08.02217916403
  • Liu Z, Lian Z, Zhou W, et al. National survey on prevalence of cancer pain. Chin Med Sci J. 2001;16(3):175–178.12899334
  • Sanford NN, Sher DJ, Butler SS, et al. Prevalence of chronic pain among cancer survivors in the United States, 2010–2017. Cancer. 2019;125(23):4310–4318. doi:10.1002/cncr.3245031436323
  • van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070–1090 e1079.27112310
  • Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32(36):4149–4154. doi:10.1200/JCO.2014.56.038325403222
  • Wei W, Bangwei C, Xiaohong N, et al. Progress and challenges in pain management in Beijing in last 20 years——multicenter investigation of cancer pain management in Beijing (FENPAI4090). Chin J Pain Med. 2014;20(1):5–12.
  • Xia Z. Cancer pain management in China: current status and practice implications based on the ACHEON survey. J Pain Res. 2017;10:1943–1952. doi:10.2147/JPR.S12853328860849
  • Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985–1991. doi:10.1093/annonc/mdn41918632721
  • Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644–1656. doi:10.1016/S0140-6736(16)00161-626852264
  • Kwon JH. Overcoming barriers in cancer pain management. J Clin Oncol. 2014;32(16):1727–1733. doi:10.1200/JCO.2013.52.482724799490
  • Jho HJ, Kim Y, Kong KA, et al. Knowledge, practices, and perceived barriers regarding cancer pain management among physicians and nurses in Korea: a nationwide multicenter survey. PLoS One. 2014;9(8):e105900. doi:10.1371/journal.pone.010590025144641
  • Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin. 2018;68(3):182–196. doi:10.3322/caac.2145329603142
  • Gunnarsdottir S, Sigurdardottir V, Kloke M, et al. A multicenter study of attitudinal barriers to cancer pain management. Support Care Cancer. 2017;25(11):3595–3602. doi:10.1007/s00520-017-3791-828653107
  • García-Mata J, Álamo C, de Castro J, et al. A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain. Clin Transl Oncol. 2018;20(8):1061–1071. doi:10.1007/s12094-017-1826-829721765
  • Breuer B, Fleishman SB, Cruciani RA, Portenoy RK. Medical oncologists’ attitudes and practice in cancer pain management: a national survey. J Clin Oncol. 2011;29(36):4769–4775. doi:10.1200/JCO.2011.35.056122084372
  • Silvoniemi M, Vasankari T, Vahlberg T, Vuorinen E, Clemens KE, Salminen E. Physicians’ self-assessment of cancer pain treatment skills–more training required. Support Care Cancer. 2012;20(11):2747–2753. doi:10.1007/s00520-012-1396-922322593
  • Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59(4):850–856. doi:10.1002/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-13802043
  • Straube C, Derry S, Jackson KC, et al.Codeine, alone and with paracetamol (acetaminophen), for cancer pain. Cochrane Database Syst Rev. 2014;(9):CD006601. doi:10.1002/14651858.CD006601.pub425234029
  • Bandieri E, Romero M, Ripamonti CI, et al. Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol. 2016;34(5):436–442. doi:10.1200/JCO.2015.61.073326644526
  • Marinangeli F, Ciccozzi A, Leonardis M, et al. Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage. 2004;27(5):409–416. doi:10.1016/j.jpainsymman.2003.10.00615120769
  • Chapman EJ, Edwards Z, Boland JW, et al. Practice review: evidence-based and effective management of pain in patients with advanced cancer. Palliat Med. 2020;34(4):444–453. doi:10.1177/026921631989695531980005
  • Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7:CD012592.28683172
  • Corli O, Floriani I, Roberto A, et al. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized Phase IV ‘real life’ trial on the variability of response to opioids. Ann Oncol. 2016;27(6):1107–1115. doi:10.1093/annonc/mdw09726940689
  • Adam R, Bond C, Murchie P. Educational interventions for cancer pain. A systematic review of systematic reviews with nested narrative review of randomized controlled trials. Patient Educ Couns. 2015;98(3):269–282. doi:10.1016/j.pec.2014.11.00325483575